awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26823757-5D2F41BA-6844-472D-A5B5-D8FB0F13D345
Q26823757-5D2F41BA-6844-472D-A5B5-D8FB0F13D345
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26823757-5D2F41BA-6844-472D-A5B5-D8FB0F13D345
Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)
P2860
Q26823757-5D2F41BA-6844-472D-A5B5-D8FB0F13D345
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26823757-5D2F41BA-6844-472D-A5B5-D8FB0F13D345
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2a78bd876e53b8a4c14feb5054b3e2bf67a5c9f3
P2860
Promotion of graft survival by photothrombotic occlusion of corneal neovascularization.